These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19271098)

  • 1. An updated systematic review of Health State Utility Values for osteoporosis related conditions.
    Peasgood T; Herrmann K; Kanis JA; Brazier JE
    Osteoporos Int; 2009 Jun; 20(6):853-68. PubMed ID: 19271098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.
    Si L; Winzenberg TM; de Graaff B; Palmer AJ
    Osteoporos Int; 2014 Aug; 25(8):1987-97. PubMed ID: 24562840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of health state utility values for osteoporosis-related conditions.
    Brazier JE; Green C; Kanis JA;
    Osteoporos Int; 2002 Oct; 13(10):768-76. PubMed ID: 12378365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Imai T; Tanaka S; Kawakami K; Miyazaki T; Hagino H; Shiraki M;
    Osteoporos Int; 2017 Jun; 28(6):1893-1901. PubMed ID: 28265719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
    Svedbom A; Borgström F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Uusküla A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
    Qual Life Res; 2018 Mar; 27(3):707-716. PubMed ID: 29235059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility values associated with osteoporotic fracture: a systematic review of the literature.
    Hiligsmann M; Ethgen O; Richy F; Reginster JY
    Calcif Tissue Int; 2008 Apr; 82(4):288-92. PubMed ID: 18404243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
    Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
    Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utility values of osteoporotic fractures among Korean women.
    Bae G; Kim E; Kwon HY; An J; Park J; Yang H
    Expert Rev Pharmacoecon Outcomes Res; 2020 Apr; 20(2):177-183. PubMed ID: 31092075
    [No Abstract]   [Full Text] [Related]  

  • 11. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Papaioannou D
    Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with osteoporosis.
    Lips P; van Schoor NM
    Osteoporos Int; 2005 May; 16(5):447-55. PubMed ID: 15609073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon kyphoplasty: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(12):1-45. PubMed ID: 23074451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M; Davis S; Lloyd-Jones M; Beverley C
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
    Gabriel SE; Kneeland TS; Melton LJ; Moncur MM; Ettinger B; Tosteson AN
    Med Decis Making; 1999; 19(2):141-8. PubMed ID: 10231076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.
    Kanis JA; Stevenson M; McCloskey EV; Davis S; Lloyd-Jones M
    Health Technol Assess; 2007 Mar; 11(7):iii-iv, ix-xi, 1-231. PubMed ID: 17311734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.
    Svedbom A; Borgstöm F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Kallikorm R; Lember M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Solodovnikov A; Tamulaitiene M; Thomas T; Toroptsova N; Uusküla A; Tosteson ANA; Jönsson B; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):557-566. PubMed ID: 29230511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.
    Brockbank J; Krause T; Moss E; Pedersen AM; Mørup MF; Ahdesmäki O; Vaughan J; Brodtkorb TH
    Health Qual Life Outcomes; 2021 Mar; 19(1):94. PubMed ID: 33736649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.